Oxyvin

Quick links to important sections

Oxyvin

Method of action: Peripheral Vasodilators

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxyvin

Oxyvin is a pharmaceutical preparation whose active component is Vincamine, a substance classified as both a cerebral vasodilator and a nootropic agent. This single-ingredient medicine is designed to specifically support circulation within the brain.

Property Description
Active ingredient Vincamine (C21H26N2O3)
Form Tablet, Capsule (Oral)
Pharmacological class Cerebral Vasodilator, Nootropic
General purpose Supports cognitive health by optimizing brain blood flow
Origin Plant-derived (Indole Alkaloid from Vinca minor)

What Type of Medicine is Oxyvin (Vincamine)?

Oxyvin is a medicine categorized primarily as a cerebral vasodilator; its function is directed at influencing blood vessels in the brain. The active substance, Vincamine, is a plant-derived monoterpenoid indole alkaloid, originally sourced from the Vinca minor (lesser periwinkle) plant. This pharmacological identity characterizes the agent as one used to promote healthy brain function and metabolism. Its profile includes effects on regional blood distribution within the central nervous system, supporting its use in cases of cerebrovascular insufficiency.


Oxyvin Composition: What is Vincamine?

The composition of Oxyvin is based on a single active ingredient, Vincamine, a complex organic molecule. For patient use, the medication is commonly formulated as a conventional tablet or a specialized capsule, including preparations designed for sustained release. These solid oral dosage forms utilize a solid excipient base and are intended for oral administration, allowing the Vincamine to be absorbed and distributed systemically to target the cerebral vasculature.


What is the General Purpose of Oxyvin?

The general purpose of Oxyvin is to support overall cognitive health by improving blood flow to brain tissues, making it typically relevant for adult patient groups experiencing age-related changes in circulation. As a cerebral vasodilator, the medication functions by helping to widen tiny blood vessels in the brain, thereby facilitating an enhanced and more reliable supply of essential oxygen and nutrients to nerve cells. This mechanism helps sustain efficient cerebrovascular function and offers a degree of neuroprotective support. The primary effect of the medicine is the enhancement of regional cerebral blood supply, which supports the brain's metabolic demands.

What side effects are possible with Oxyvin?

Possible Side Effects and Safety Information

The safety profile of Oxyvin (Vincamine) is formally classified in regulatory documents according to the likelihood and type of adverse reactions observed. Adverse reactions are grouped by the affected System-Organ Class (SOC), providing a structured overview of potential effects.


Officially Documented Adverse Reactions

Side effects are categorized by frequency, based on official regulatory standards:

  • Common Reactions (1/100 to 1/10): These effects primarily involve the Gastrointestinal and Nervous Systems, and may include nausea, heartburn, headache, and dizziness.
  • Uncommon Reactions (1/1,000 to 1/100): This category includes Skin and Subcutaneous Tissue Disorders, such as pruritus or rash.

Serious Safety Concerns and Contraindications

The most critical safety information documented in regulatory monographs involves the Cardiac System. Vincamine has been formally associated with a rare risk of QT interval prolongation on the electrocardiogram, which can lead to ventricular arrhythmias, including Torsades de Pointes. Severe bradycardia is also listed as a serious adverse reaction.

This risk profile establishes several strict Contraindications:

  • Pre-existing Conditions: Oxyvin is contraindicated in patients with a known prolonged QT interval, severe bradycardia (under 50 beats per minute), or cardiac failure. Use is also prohibited in cases of acute stroke and intracranial hypertension.
  • Special Populations: The medicine is contraindicated during pregnancy, lactation, and for use in pediatric patients. Caution is advised when administering Oxyvin to individuals with severe hepatic impairment.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation states that an overdose of Oxyvin (Vincamine) is associated with distinct effects on the cardiovascular and central nervous systems. These manifestations typically occur when exposure significantly exceeds the recommended therapeutic dosage.

Manifestation Category Documented Clinical Signs and Symptoms
Cardiovascular Effects Hypotension (low blood pressure), Bradycardia (slow heart rate), and Dizziness.
Neurological Effects Sedation, Drowsiness, and potential Loss of Consciousness.
Gastrointestinal Effects Vomiting.

Required Emergency Actions

In the event of a suspected or confirmed overdose, regulatory authorities mandate that patients seek immediate medical attention. This urgent action is required due to the potential for severe, life-threatening outcomes, including critical or prolonged hypotension and dangerous cardiac arrhythmias. Immediate contact with emergency services or a poison control center is advised if severe symptoms, such as loss of consciousness or profound instability, are observed.

Official Management Protocols

The official prescribing information confirms that no specific antidote is known for Vincamine overdosage. Therefore, treatment is defined as strictly symptomatic and supportive care. Hospital management, which may be required, includes procedures such as continuous cardiac monitoring (ECG/EKG) and general measures like intravenous fluid administration to stabilize blood pressure. Gastric decontamination, such as gastric lavage and activated charcoal, may also be considered. Extended hospital observation is necessary to monitor for any delayed toxicity or recurrence of severe symptoms.

Therapeutic Uses of Oxyvin

What Oxyvin Treats: Main Uses and Benefits

Oxyvin (Vincamine) is commonly used to provide specialized support for brain function in situations involving chronic circulatory deficits, focusing on managing functional deficits and the easing of associated symptoms. The application of Vincamine is associated with its ability to modulate regional cerebral circulation, aligning with its primary use in supporting vascular health.

This medication is relevant for managing symptom clusters that may interfere with daily functioning, such as difficulties with concentration, short-term memory impairment, chronic dizziness, certain forms of vertigo associated with poor circulation, and vascular-related headaches.

“The use of Vincamine is relevant in contexts requiring additional support for cerebrovascular function, particularly where chronic deficits contribute to noticeable cognitive or sensory symptoms.”

Supporting Cognitive Health and Stability

The medication is commonly applied in the therapeutic domain of vascular cognitive deficits, which may present as mild-to-moderate impairments. This use may help address symptom clusters associated with chronic cerebrovascular insufficiency, which contributes to supporting general cognitive stability. Oxyvin is typically utilized as a long-term maintenance therapy for older adult patients or those with confirmed vascular risk factors.


Quick Fact: Support for Neuro-Sensory Disturbances Oxyvin may assist with managing symptoms that interfere with daily functioning, such as chronic dizziness or vertigo, which supports improved comfort during symptomatic periods.

Eligibility and Restrictions for Use

The eligibility for Oxyvin (Vincamine) is strictly defined by regulatory documents, confining its authorized use to specific populations for whom safety is established. The medicine is primarily indicated for use in adult patient groups and older adults for the chronic management of cerebral circulatory deficits.

Official labeling establishes several absolute contraindications. Oxyvin must not be used by individuals with documented hypersensitivity to Vincamine, other vinca alkaloids, or any excipients. Use is strictly prohibited in cases of acute cerebral hemorrhage due to the risk associated with its vascular effects, and in patients with severe cardiac arrhythmias, such as known congenital or acquired QT interval prolongation.

The medicine is not recommended for the pediatric population (individuals under 18 years of age) because safety and efficacy data are not established. Use is also contraindicated during pregnancy, and it is not recommended for women who are breastfeeding, a position reflecting regulatory warnings citing the potential for developmental risks. Restrictions also apply to patients with existing conditions, advising caution in cases of severe hepatic impairment and severe renal impairment where use is restricted due to limited safety documentation.

What should I know about interactions with other medicines?

Oxyvin's metabolism in the body involves the Cytochrome P450 enzyme system, specifically the CYP3A4 and CYP2D6 pathways. This metabolic route forms the basis of several clinically significant drug-drug interactions.

Interacting Medicines and Classes

Product Category Interaction Mechanism Classification
CNS Depressants (e.g., benzodiazepines, alcohol, hypnotics) Additive pharmacodynamic effects High Risk (Profound Sedation, Respiratory Depression)
Strong CYP3A4 Inhibitors (e.g., ketoconazole, macrolide antibiotics) Decreased metabolism of Oxyvin, increasing blood levels High Risk (Increased Adverse Effects)
Strong CYP3A4 Inducers (e.g., rifampin, phenytoin) Increased metabolism of Oxyvin, potentially reducing efficacy Moderate Risk (Reduced Therapeutic Effect)
Monoamine Oxidase Inhibitors (MAOIs) Serotonergic and/or CNS-potentiating effects Contraindicated (Serious, potentially fatal reactions)

Co-administration with other CNS depressants should be reserved only for cases where non-alternative treatment options are available, and requires close monitoring for signs of sedation or respiratory distress. Oxyvin should not be used in patients receiving MAOIs or within 14 days of discontinuing MAOI therapy. The use of strong CYP3A4 inhibitors may necessitate a dose reduction of Oxyvin, while strong CYP3A4 inducers may require a dose increase.

Mechanism of Action

Oxyvin (Vincamine) operates through a dual mechanistic approach, targeting both the vascular structures and the protective systems of the central nervous system. This design contributes to sustained metabolic activity and supports the structural integrity of nerve cells.

Selective Modulation of Cerebral Blood Flow

The primary action involves the direct modulation of vascular smooth muscle in the cerebral microcirculation. By reducing resistance within the small blood vessels of the brain, the drug facilitates a selective increase in regional cerebral blood flow ( rCBF) and oxygen utilization. This physiological change represents a core hemodynamic consequence of the mechanism, facilitating the delivery of oxygen and glucose to hypoperfused cerebral regions.

Cellular Neuroprotection and Homeostasis Support

Oxyvin's mechanism extends to cellular pathway modulation, involving the suppression of pro-inflammatory factors ( NF-kappa B) and the activation of the Nrf2 antioxidant defense system. This dual engagement supports the stability of neuronal membranes and modulates cellular degradation pathways linked to chronic oxidative stress and inflammatory mediators , thereby contributing to the regulation of cellular integrity.

Dosage and Administration Information

How to Use Oxyvin

Oxyvin administration is based on established parameters for routes, dosing schedules, and duration patterns. This information describes the characteristic application and management of the medication.


Official Administration Guidelines

Field Guideline
Route of Administration Oral (Tablet/Capsule), Intravenous (IV) Infusion, and Intramuscular (IM) Injection.
Dosing Schedule The standard total daily dose for adults typically ranges from 10 mg to 40 mg (total per day).
Frequency Pattern Daily use, prescribed in divided doses (e.g., two to three times per day) to maintain stable systemic levels.
Target Population Primarily directed toward adult and older adult patient groups.
Duration Pattern Designated for use as a long-term maintenance therapy for chronic conditions.

Procedural Administration Constraints

The most common method of administration is the oral route via a tablet or capsule, which is taken according to the prescribed daily schedule. For situations requiring parenteral use, the injectable solution must be diluted and prepared. A critical constraint for the intravenous route is the requirement for slow infusion to ensure appropriate administration technique. These procedural details establish the required framework for the administration of Oxyvin.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Oxyvin (Vincamine)

Evidence for Use in Chronic Cerebrovascular Insufficiency and Associated Symptoms

Research into the use of Oxyvin (Vincamine) was evaluated in studies focused on chronic circulatory conditions, which were conditions characterized by fluctuating or episodic manifestations. This area of research primarily includes historical randomized controlled trials (RCTs) and specialized pharmacological studies. The research examined older adults, often aged 50 and above, who were enrolled based on symptoms such as chronic dizziness or functional limitations.

The studies monitored outcomes across several domains. First, researchers evaluated objective outcomes by measuring changes in cerebral blood flow (CBF) and measures of cerebral metabolism. Second, the research explored patient-reported outcomes describing perceived discomfort, such as dizziness, chronic headaches, and vertigo. The findings describe patterns observed in the studies related to outcomes related to systemic or functional imbalance. However, the evidence is limited by small sample sizes in many of the primary trials, and findings were mixed or inconsistent across the full body of published studies.


Evidence for Use in Vascular and Degenerative Cognitive Impairment

Oxyvin was studied for its application in mild-to-moderate cognitive deficits, which are conditions marked by functional limitations related to memory and thinking. The main research foundation for this area relies on historical RCTs which have been aggregated and reviewed in subsequent systematic reviews and meta-analyses.

These trials researched populations of older adults with diagnoses of both vascular cognitive impairment and some degenerative forms of cognitive decline. The primary focus was evaluated in standardized cognitive function scales (e.g., MMSE or SKT). Systematic reviews often conclude that the findings were mixed or that the evidence remains insufficient to draw definitive conclusions regarding efficacy.


What is Still Uncertain About the Research Evidence

The existing research highlights several limitations. The evidence is limited due to factors such as small sample sizes in the primary studies and follow-up durations were limited for documenting long-lasting effects. The findings describe group patterns, not personal outcomes, and should be viewed within the context of the trials. Furthermore, the evidence quality varies across studies, and there is limited information available from comparative research.

Frequently Asked Questions (FAQ)

Common questions about Oxyvin (FAQ)


Q: How quickly should I expect Oxyvin to start working?

A: Studies and official information indicate that the initial therapeutic activity of the active ingredient may begin after approximately one week. The full therapeutic effect may require consistent use over several months.


Q: How long does the effect of one dose of Oxyvin last?

A: Official administration guidelines indicate that Oxyvin is prescribed for daily use in divided doses, such as two to three times per day. This dosing frequency is intended to maintain generally stable systemic levels of the medicine.


Q: Does Oxyvin cause fatigue or drowsiness?

A: Dizziness is formally listed as a common reaction involving the nervous system in regulatory documents. However, the specific terms fatigue or drowsiness are not listed in the 'Common Reactions' section of the official documents.


Q: Is it common to feel nauseous when taking Oxyvin?

A: Yes, regulatory documents classify nausea as a Common Reaction to Oxyvin. This means that, based on clinical trials, it has been reported by approximately 1 out of every 10 to 100 patients taking the medicine.


Q: Is it normal to have mild headaches when starting Oxyvin?

A: Yes, headache is formally listed in regulatory documents as a Common Reaction to Oxyvin. As with any adverse effect, monitoring changes and consulting a healthcare professional are important steps.


Q: Can Oxyvin change my mood or cause anxiety?

A: Adverse effects involving the Nervous System are documented in the official safety profile. While specific mood changes are not listed as Common, related compounds have reported side effects such as anxiety.


Q: How is the long-term benefit of Oxyvin measured in studies?

A: Studies on the long-term benefit of Oxyvin measure two main areas. They track objective outcomes, such as changes in cerebral blood flow and metabolism. They also track patient-reported outcomes, such as changes in chronic symptoms like dizziness and headaches.


Q: Does food change how well Oxyvin is absorbed?

A: Official administration guidelines often recommend taking the oral dosage form after a meal. This recommendation supports consistent administration as defined in the official guidelines.


Q: Is Oxyvin considered a controlled substance?

A: The active ingredient in Oxyvin, Vincamine, is generally not classified as a controlled substance under the schedules defined by major international regulatory bodies. It is classified as a prescription-only medicine.


Q: Does Oxyvin affect sleep patterns?

A: Adverse effects involving the Nervous System are documented in official safety information. Sleep problems have been noted in the side effect profiles of chemically related compounds.


Q: What happens if I miss a dose of Oxyvin?

A: Regulatory documents describe a general approach for missed doses, which usually involves taking the dose when remembered unless the next scheduled dose is imminent. The guidance typically states that if the next scheduled dose is imminent, the missed dose should be skipped, and taking a double dose is not advised in these situations.


Q: Is Oxyvin the same as (similar drug name)?

A: Oxyvin is the brand name for the active ingredient Vincamine. In medical classification, a medicine with a different active component is distinct from Oxyvin.


Q: Can Oxyvin be crushed or chewed?

A: The official product information specifies the dosage form as a tablet or capsule intended for oral administration. Crushing or chewing is generally not covered by the official guidelines for administration, particularly for dosage forms like capsules or modified-release tablets, where it may alter the intended release of the active ingredient.


Q: Are there different strengths of Oxyvin available?

A: Yes, the medicine is typically available in various strengths of the oral tablet or capsule dosage form. This permits flexibility in achieving the prescribed total daily dose.


Q: What does the FDA / EMA say about the safety of Oxyvin?

A: Regulatory bodies like the EMA and FDA have assessed the safety profile and document the serious, rare risk of QT interval prolongation on the electrocardiogram. This leads to strict contraindications for use in severe cardiac conditions.


Q: Does Oxyvin require a special prescription or monitoring?

A: Oxyvin is a prescription-only medicine. While regulatory documents do not specify a special restricted prescribing program, close monitoring is required in cases of co-administration with other medicines like Central Nervous System (CNS) depressants.


Q: Why does the official document warn about (specific side effect)?

A: Official warnings about serious side effects, such as the risk of QT interval prolongation, are based on clinical data that showed an association between the medicine and changes in heart rhythm. These changes can potentially lead to serious ventricular arrhythmias (irregular heartbeats).


Q: How long can a person safely stay on Oxyvin?

A: Oxyvin is officially designated for use as a long-term maintenance therapy for chronic conditions. The duration of therapy is generally guided by the prescribed regimen and the need for ongoing evaluation.


Q: What color are the Oxyvin pills usually?

A: The specific commercial color and appearance of the tablets or capsules are defined by the manufacturer. The active ingredient, Vincamine, is typically described as a white to off-white crystalline powder.


Q: Are there any dietary restrictions needed when using Oxyvin?

A: Official regulatory documents do not list specific dietary restrictions that must be followed while using this medicine. Only interactions with other medicines and alcohol are usually specified.


Q: Can Oxyvin cause dizziness or problems with balance?

A: Dizziness is formally listed as a Common Reaction in official regulatory safety documents. If dizziness occurs, caution is generally recommended.


Q: Is it mandatory to take Oxyvin exactly at the same time every day?

A: Regulatory documents specify a fixed schedule of divided daily doses to help maintain stable systemic levels of the medicine. Consistent timing helps support the stable systemic levels that the divided dose schedule is designed to achieve.


Q: Is Oxyvin a generic or a brand-name drug?

A: Oxyvin is described as a pharmaceutical preparation containing the active ingredient Vincamine. Vincamine is the generic name of the substance, which can be marketed under various brand names.


Q: What is the shelf life or expiry of Oxyvin tablets?

A: The specific shelf life and expiration date are key factual details determined by the manufacturer based on regulatory testing and approval. This information is typically included on the product packaging.


Q: Does Oxyvin interact with birth control pills?

A: Oxyvin's metabolism involves the CYP3A4 enzyme system. Regulatory documents advise considering potential interactions with other medicines metabolized by or influencing this pathway, which may include certain hormonal contraceptives.


Q: Are allergic reactions to Oxyvin common?

A: While Hypersensitivity (severe allergic reaction) is a formal contraindication, related skin and subcutaneous tissue reactions such as rash or itching are listed as Uncommon Reactions. This means they are reported in 1 out of 100 to 1,000 patients.


Q: What happens when you stop taking Oxyvin suddenly?

A: Official product guidelines for discontinuing the medicine are not explicitly summarized. For long-term therapies like Oxyvin, the official documentation generally recommends seeking guidance on how to cease treatment.


Q: Is Oxyvin safe for people with high blood pressure?

A: High blood pressure is not listed as a formal contraindication for Oxyvin. However, caution is advised for individuals with existing cardiovascular conditions or hypotension (low blood pressure) due to its vascular effects.

How should Oxyvin be stored and disposed of?

How to Store and Dispose of Oxyvin (Vincamine)

Oxyvin (Vincamine) must be stored and handled according to regulatory requirements to preserve its stability and prevent accidental exposure.


Storage Requirements

The medication must be kept at a controlled room temperature, typically below 30 C. It is crucial to protect the product from moisture and light; therefore, it should be kept in its original container with the lid tightly closed. Do not freeze or refrigerate Oxyvin. As with all medicines, it must be stored out of the sight and reach of children to ensure safety.


Disposal Instructions

Unused or expired Oxyvin must not be thrown into household waste or flushed down the toilet. The official method for disposal is to return the medicine to a pharmacist or a recognized local drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxyvin found in:

A-Z Index: